Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects

OBJECTIVE: In the treatment of diabetic patients, the long-acting insulin analog insulin detemir is less prone to induce weight gain than other insulin formulations. Assuming that because of its pharmacologic properties, detemir displays stronger central nervous anorexigenic efficacy than human insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallschmid, Manfred, Jauch-Chara, Kamila, Korn, Oliver, Mölle, Matthias, Rasch, Björn, Born, Jan, Schultes, Bernd, Kern, Werner
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844819/
https://www.ncbi.nlm.nih.gov/pubmed/20068139
http://dx.doi.org/10.2337/db09-1493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844819/
https://www.ncbi.nlm.nih.gov/pubmed/20068139
http://dx.doi.org/10.2337/db09-1493

Ejemplares similares